Seeking Alpha

TROV
  TrovaGene, Inc. - NASDAQ

8/23/2014, 12:43 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
TROV vs. ETF Alternatives
Company Description
TrovaGene, Inc., is a development stage molecular diagnostic company. It focuses on the development and marketing of urine-based nucleic acid tests for patient/disease screening and monitoring.
Sector: Healthcare
Industry: Biotechnology
Country: United States